Evolent Health, INC Form 4 insider transactions

Mary Bridget Duffy, a director at Evolent Health, reported the acquisition of restricted stock units and a transfer of shares due to a domestic relations order.

Director Kim Keck reports acquisition of restricted stock units in Evolent Health, Inc.

Director Russell Monroe Glass reports acquisition of restricted stock units and changes in Class A Common Stock holdings.

Director Toyin Ajayi received 7,709 shares of Evolent Health Class A Common Stock as restricted stock units on June 6, 2024.

Richard Jelinek, a director at Evolent Health, Inc., reported the acquisition of restricted stock units (RSUs) under the company's 2015 Omnibus Incentive Compensation Plan.

Director Craig Barbarosh acquired 7,709 shares of Evolent Health, Inc. through restricted stock units.

Steve Tutewohl, Chief Operating Officer of Evolent Health, reports changes in beneficial ownership due to the vesting and forfeiture of restricted stock units following his departure from the company.

Director Russell Monroe Glass reports acquisition of 1,163 restricted stock units in Evolent Health, Inc.

Aammaad Shams, Chief Accounting Officer of Evolent Health, Inc., reports acquisition and disposal of Class A Common Stock and restricted stock units.

Emily Ann Rafferty, Chief Operating Officer of Evolent Health, Inc., reports acquisition of restricted stock units and disposition of shares to cover tax obligations.

Jonathan Weinberg, General Counsel of Evolent Health, reports acquisition and disposal of Class A Common Stock due to vesting of restricted stock units and tax withholding.

John Paul Johnson, CFO of Evolent Health, reports acquisition and disposal of Class A Common Stock related to restricted stock units.

CEO Seth Blackley reports acquisition of restricted stock units and disposal of shares to cover tax obligations.

Daniel McCarthy, President of Evolent Health, reports acquisition and disposal of Class A Common Stock due to vesting of restricted stock units and tax obligations.